AQW 19095/17-22

Mr Stewart Dickson
Alliance Party
East Antrim

Tabled Date: 19/05/2021
Answered On Date: 10/06/2021
Priority Written: No

Question:
To ask the Minister of Health to detail the number of patients that could benefit from Tagrisso (Osimertinib) as a post-surgery treatment for early-stage lung cancer.

Answer:

Precise figures on the number of patients that could benefit from Tagrisso (osimertinib) as a post-surgery treatment for early-stage lung cancer are not available.

I wish to offer the assurance that patients in Northern Ireland will have the same access to Tagrisso as patients in the rest of the United Kingdom, within the National Institute for Health and Clinical Excellence (NICE) guidelines.